Edda Frauke Spiekerkoetter MD
Critical Care Medicine
Acting Assistant Professor, Medicine - Pulmonary & Critical Care Medicine, Stanford University Medical Center
Dr. Spiekerkoetter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2009
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2008
- Albert Ludwigs University Faculty of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 2009 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- FK506 (Tacrolimus) in Pulmonary Arterial Hypertension Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 1 citationsCardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension-The Right Ventricle as a Therapeutic Target to Improve Renal Function.Kenzo Ichimura, Adam Gross, Roy O Mathew, Loay Salman, Sushma Reddy
Cardiovascular Drugs and Therapy. 2025-04-01 - Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited - A Multigenerational Perspective.Grazyna Kwapiszewska, Christopher Rhodes, Marlene Rabinovitch, Catherine Simpson, Paul Hassoun
American Journal of Respiratory Cell and Molecular Biology. 2025-03-28 - 1 citationsProtocol for efficient generation of human artery and vein endothelial cells from pluripotent stem cells.Kyle M Loh, Sherry Li Zheng, Kevin J Liu, Qingqing Yin, Zhainib A Amir-Ugokwe
STAR Protocols. 2025-03-21
Grant Support
- Understanding and targeting molecular and cellular events responsible for pulmonary arteriovenous malformation development, growth and regressionSTANFORD UNIVERSITY2023–2027
- Vasculata 2024STANFORD UNIVERSITY2024–2025
- Understanding and targeting molecular as well as structural events governing right ventricular adaptation, failure and recovery in pulmonary hypertension using repurposed drugsSTANFORD UNIVERSITY2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: